MovDisordV3, PubMed, Corpus, bibRecord, 001626

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Identifieur interne : 001626 ( PubMed/Corpus ); précédent : 001625; suivant : 001627

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Auteurs : Atbin Djamshidian ; Ashwani Jha ; Sean S. O'Sullivan ; Laura Silveira-Moriyama ; Clare Jacobson ; Peter Brown ; Andrew Lees ; Bruno B. Averbeck

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.

RBID : pubmed:20721918

English descriptors

KwdEn :
- Aged, Analysis of Variance, Female, Humans, Impulsive Behavior (etiology), Learning (physiology), Male, Memory, Short-Term (physiology), Middle Aged, Neuropsychological Tests, Parkinson Disease (complications), Risk Factors.
MESH :
- complications : Parkinson Disease.
- etiology : Impulsive Behavior.
- physiology : Learning, Memory, Short-Term.
- Aged, Analysis of Variance, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Risk Factors.

Abstract

Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the results with those in a group of age-matched control subjects. Parkinson patients with PD+ICB had poorer working memory performance than either controls or PD patients without ICB. PD+ICB patients also showed decreased learning from negative feedback and increased learning from positive feedback in off compared with on dopaminergic medication. This interaction between medication status and learning was the opposite of that found in the PD patients without a diagnosis of ICB. Finally, the PD group showed increased risk preference on medication relative to controls, and the subgroup of PD+ICB patients with pathological gambling were overall more risk prone than the PD group. Thus, medication status and an impulsive behavioral diagnosis differentially affect several behaviors in PD.

DOI: 10.1002/mds.23247
PubMed: 20721918

Links to Exploration step

pubmed:20721918

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.</title>
<author><name sortKey="Djamshidian, Atbin" sort="Djamshidian, Atbin" uniqKey="Djamshidian A" first="Atbin" last="Djamshidian">Atbin Djamshidian</name>
<affiliation><nlm:affiliation>Department of Molecular Neuroscience and Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jha, Ashwani" sort="Jha, Ashwani" uniqKey="Jha A" first="Ashwani" last="Jha">Ashwani Jha</name>
</author>
<author><name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S" last="O'Sullivan">Sean S. O'Sullivan</name>
</author>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
</author>
<author><name sortKey="Jacobson, Clare" sort="Jacobson, Clare" uniqKey="Jacobson C" first="Clare" last="Jacobson">Clare Jacobson</name>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
</author>
<author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
</author>
<author><name sortKey="Averbeck, Bruno B" sort="Averbeck, Bruno B" uniqKey="Averbeck B" first="Bruno B" last="Averbeck">Bruno B. Averbeck</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23247</idno>
<idno type="RBID">pubmed:20721918</idno>
<idno type="pmid">20721918</idno>
<idno type="wicri:Area/PubMed/Corpus">001626</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.</title>
<author><name sortKey="Djamshidian, Atbin" sort="Djamshidian, Atbin" uniqKey="Djamshidian A" first="Atbin" last="Djamshidian">Atbin Djamshidian</name>
<affiliation><nlm:affiliation>Department of Molecular Neuroscience and Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jha, Ashwani" sort="Jha, Ashwani" uniqKey="Jha A" first="Ashwani" last="Jha">Ashwani Jha</name>
</author>
<author><name sortKey="O Sullivan, Sean S" sort="O Sullivan, Sean S" uniqKey="O Sullivan S" first="Sean S" last="O'Sullivan">Sean S. O'Sullivan</name>
</author>
<author><name sortKey="Silveira Moriyama, Laura" sort="Silveira Moriyama, Laura" uniqKey="Silveira Moriyama L" first="Laura" last="Silveira-Moriyama">Laura Silveira-Moriyama</name>
</author>
<author><name sortKey="Jacobson, Clare" sort="Jacobson, Clare" uniqKey="Jacobson C" first="Clare" last="Jacobson">Clare Jacobson</name>
</author>
<author><name sortKey="Brown, Peter" sort="Brown, Peter" uniqKey="Brown P" first="Peter" last="Brown">Peter Brown</name>
</author>
<author><name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
</author>
<author><name sortKey="Averbeck, Bruno B" sort="Averbeck, Bruno B" uniqKey="Averbeck B" first="Bruno B" last="Averbeck">Bruno B. Averbeck</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Analysis of Variance</term>
<term>Female</term>
<term>Humans</term>
<term>Impulsive Behavior (etiology)</term>
<term>Learning (physiology)</term>
<term>Male</term>
<term>Memory, Short-Term (physiology)</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
<term>Parkinson Disease (complications)</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Impulsive Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Learning</term>
<term>Memory, Short-Term</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Analysis of Variance</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the results with those in a group of age-matched control subjects. Parkinson patients with PD+ICB had poorer working memory performance than either controls or PD patients without ICB. PD+ICB patients also showed decreased learning from negative feedback and increased learning from positive feedback in off compared with on dopaminergic medication. This interaction between medication status and learning was the opposite of that found in the PD patients without a diagnosis of ICB. Finally, the PD group showed increased risk preference on medication relative to controls, and the subgroup of PD+ICB patients with pathological gambling were overall more risk prone than the PD group. Thus, medication status and an impulsive behavioral diagnosis differentially affect several behaviors in PD.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20721918</PMID>
<DateCreated><Year>2010</Year>
<Month>10</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>01</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>13</Issue>
<PubDate><Year>2010</Year>
<Month>Oct</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>2203-10</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23247</ELocationID>
<Abstract><AbstractText>Relatively little is known about the interaction between behavioral changes, medication, and cognitive function in Parkinson's disease (PD). We examined working memory, learning and risk aversion in PD patients with and without impulsive or compulsive behavior (ICB) and compared the results with those in a group of age-matched control subjects. Parkinson patients with PD+ICB had poorer working memory performance than either controls or PD patients without ICB. PD+ICB patients also showed decreased learning from negative feedback and increased learning from positive feedback in off compared with on dopaminergic medication. This interaction between medication status and learning was the opposite of that found in the PD patients without a diagnosis of ICB. Finally, the PD group showed increased risk preference on medication relative to controls, and the subgroup of PD+ICB patients with pathological gambling were overall more risk prone than the PD group. Thus, medication status and an impulsive behavioral diagnosis differentially affect several behaviors in PD.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Djamshidian</LastName>
<ForeName>Atbin</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Neuroscience and Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jha</LastName>
<ForeName>Ashwani</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>O'Sullivan</LastName>
<ForeName>Sean S</ForeName>
<Initials>SS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Silveira-Moriyama</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jacobson</LastName>
<ForeName>Clare</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lees</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Averbeck</LastName>
<ForeName>Bruno B</ForeName>
<Initials>BB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>F-0903</GrantID>
<Agency>Parkinson's UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>G0400617</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant><GrantID>Z99 MH999999</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>ZIA MH002928-01</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Psychopharmacology (Berl). 2010 Jan;207(4):645-59</RefSource>
<PMID Version="1">19838863</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Neurol Neurosci Rep. 2006 Jul;6(4):302-6</RefSource>
<PMID Version="1">16822350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 1988 Apr;111 ( Pt 2):299-321</RefSource>
<PMID Version="1">3378138</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1988 Apr 7;318(14):876-80</RefSource>
<PMID Version="1">3352672</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):97-100</RefSource>
<PMID Version="1">3884742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Psychiatr Res. 1975 Nov;12(3):189-98</RefSource>
<PMID Version="1">1202204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Int Neuropsychol Soc. 2004 Jul;10(4):590-8</RefSource>
<PMID Version="1">15327737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Neurol. 2003 Oct;2(10):595-604</RefSource>
<PMID Version="1">14505581</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2003;41(11):1431-41</RefSource>
<PMID Version="1">12849761</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Consult Clin Psychol. 2000 Oct;68(5):818-29</RefSource>
<PMID Version="1">11068968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2004 Apr;19(4):397-405</RefSource>
<PMID Version="1">15077237</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2010 Jun 15;25(8):1026-33</RefSource>
<PMID Version="1">20131391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Psychiatry. 1994 Jun;55(6):242-8</RefSource>
<PMID Version="1">8071278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Emotion. 2009 Oct;9(5):599-608</RefSource>
<PMID Version="1">19803582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 Sep;132(Pt 9):2396-402</RefSource>
<PMID Version="1">19567700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2006 Aug 31;442(7106):1042-5</RefSource>
<PMID Version="1">16929307</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2006 Oct 10;67(7):1254-7</RefSource>
<PMID Version="1">16957130</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Neurol. 2007 Feb;64(2):212-6</RefSource>
<PMID Version="1">17296836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2007 May 16;27(20):5506-14</RefSource>
<PMID Version="1">17507572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychopharmacology. 2007 Jul;32(7):1583-99</RefSource>
<PMID Version="1">17164816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochem Pharmacol. 2008 Jan 1;75(1):63-75</RefSource>
<PMID Version="1">17719013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuroscientist. 2008 Aug;14(4):381-95</RefSource>
<PMID Version="1">18660464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurosci. 2009 Feb 4;29(5):1538-43</RefSource>
<PMID Version="1">19193900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuron. 2009 Feb 26;61(4):502-10</RefSource>
<PMID Version="1">19249271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parkinsonism Relat Disord. 2009 Mar;15(3):226-31</RefSource>
<PMID Version="1">18595765</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 May;132(Pt 5):1376-85</RefSource>
<PMID Version="1">19346328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</RefSource>
<PMID Version="1">2841426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2006;44(10):1663-73</RefSource>
<PMID Version="1">16730032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurology. 2006 Jun 13;66(11):1750-2</RefSource>
<PMID Version="1">16769956</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Neurol. 2006 May;59(5):852-8</RefSource>
<PMID Version="1">16557571</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuron. 2006 Mar 2;49(5):765-75</RefSource>
<PMID Version="1">16504951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neurosci Biobehav Rev. 2006;30(1):1-23</RefSource>
<PMID Version="1">15935475</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Neuropsychologia. 2005;43(6):823-32</RefSource>
<PMID Version="1">15716155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychiatry Res. 2005 Jan 30;133(1):91-9</RefSource>
<PMID Version="1">15698681</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 2004 Dec 10;306(5703):1940-3</RefSource>
<PMID Version="1">15528409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 1995 Aug 17;376(6541):572-5</RefSource>
<PMID Version="1">7637804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brain. 2009 Sep;132(Pt 9):2385-95</RefSource>
<PMID Version="1">19416950</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000704">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007175">Impulsive Behavior</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007858">Learning</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008570">Memory, Short-Term</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS292472</OtherID>
<OtherID Source="NLM">PMC3093055</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>1</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.23247</ArticleId>
<ArticleId IdType="pubmed">20721918</ArticleId>
<ArticleId IdType="pmc">PMC3093055</ArticleId>
<ArticleId IdType="mid">NIHMS292472</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001626 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001626 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20721918
   |texte=   Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:20721918" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki